4//SEC Filing
Calabrese Salvatore 4
Accession 0001209191-22-042572
CIK 0001819411other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:37 PM ET
Size
11.7 KB
Accession
0001209191-22-042572
Insider Transaction Report
Form 4
Calabrese Salvatore
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-07-15+59,400→ 59,400 totalExercise: $4.01Exp: 2032-07-15→ Common Stock (59,400 underlying) - Award
Restricted Stock Units
2022-07-15+9,900→ 9,900 total→ Common Stock (9,900 underlying)
Footnotes (3)
- [F1]The shares underlying the option shall vest 25% on July 1, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F3]The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001851958
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:37 PM ET
- Size
- 11.7 KB